Torrent Pharmaceuticals Limited (TORNTPHARM) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Torrent Pharmaceuticals Limited (TORNTPHARM) has a cash flow conversion efficiency ratio of 0.123x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Rs10.38 Billion ≈ $112.26 Million USD) by net assets (Rs84.49 Billion ≈ $913.73 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Torrent Pharmaceuticals Limited - Cash Flow Conversion Efficiency Trend (2005–2025)
This chart illustrates how Torrent Pharmaceuticals Limited's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read how much debt does Torrent Pharmaceuticals Limited carry for a breakdown of total debt and financial obligations.
Torrent Pharmaceuticals Limited Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Torrent Pharmaceuticals Limited ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Sprott Physical Silver
TO:PSLV
|
0.006x |
|
CF Industries Holdings Inc
NYSE:CF
|
0.138x |
|
Azrieli Group Ltd
TA:AZRG
|
0.017x |
|
Rogers Communications Inc
TO:RCI-B
|
0.072x |
|
Ningbo Tuopu Group Co Ltd
SHG:601689
|
0.022x |
|
Falabella
SN:FALABELLA
|
0.018x |
|
LI AUTO INC. (SP.ADR)/2
F:L87A
|
N/A |
|
VODACOM GROUP LTD. SP.ADR
F:5VD0
|
N/A |
Annual Cash Flow Conversion Efficiency for Torrent Pharmaceuticals Limited (2005–2025)
The table below shows the annual cash flow conversion efficiency of Torrent Pharmaceuticals Limited from 2005 to 2025. For the full company profile with market capitalisation and key ratios, see TORNTPHARM market cap.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-03-31 | Rs75.91 Billion ≈ $820.94 Million |
Rs25.85 Billion ≈ $279.56 Million |
0.341x | -28.51% |
| 2024-03-31 | Rs68.56 Billion ≈ $741.47 Million |
Rs32.66 Billion ≈ $353.21 Million |
0.476x | +24.69% |
| 2023-03-31 | Rs61.98 Billion ≈ $670.29 Million |
Rs23.68 Billion ≈ $256.09 Million |
0.382x | +26.14% |
| 2022-03-31 | Rs59.53 Billion ≈ $643.79 Million |
Rs18.03 Billion ≈ $194.99 Million |
0.303x | -12.07% |
| 2021-03-31 | Rs58.37 Billion ≈ $631.27 Million |
Rs20.11 Billion ≈ $217.45 Million |
0.344x | +19.37% |
| 2020-03-31 | Rs48.23 Billion ≈ $521.61 Million |
Rs13.92 Billion ≈ $150.52 Million |
0.289x | -24.18% |
| 2019-03-31 | Rs47.24 Billion ≈ $510.92 Million |
Rs17.98 Billion ≈ $194.46 Million |
0.381x | +96.76% |
| 2018-03-31 | Rs46.23 Billion ≈ $499.93 Million |
Rs8.94 Billion ≈ $96.70 Million |
0.193x | -16.90% |
| 2017-03-31 | Rs43.51 Billion ≈ $470.50 Million |
Rs10.13 Billion ≈ $109.52 Million |
0.233x | -70.92% |
| 2016-03-31 | Rs33.89 Billion ≈ $366.56 Million |
Rs27.13 Billion ≈ $293.43 Million |
0.800x | +146.11% |
| 2015-03-31 | Rs24.91 Billion ≈ $269.39 Million |
Rs8.10 Billion ≈ $87.62 Million |
0.325x | +3.25% |
| 2014-03-31 | Rs19.03 Billion ≈ $205.78 Million |
Rs5.99 Billion ≈ $64.82 Million |
0.315x | +191.92% |
| 2013-03-31 | Rs14.22 Billion ≈ $153.82 Million |
Rs1.53 Billion ≈ $16.60 Million |
0.108x | -74.53% |
| 2012-03-31 | Rs11.97 Billion ≈ $129.49 Million |
Rs5.07 Billion ≈ $54.87 Million |
0.424x | +9.98% |
| 2011-03-31 | Rs10.24 Billion ≈ $110.74 Million |
Rs3.95 Billion ≈ $42.67 Million |
0.385x | +11.56% |
| 2010-03-31 | Rs8.31 Billion ≈ $89.87 Million |
Rs2.87 Billion ≈ $31.04 Million |
0.345x | -12.83% |
| 2009-03-31 | Rs6.51 Billion ≈ $70.39 Million |
Rs2.58 Billion ≈ $27.89 Million |
0.396x | -16.47% |
| 2008-03-31 | Rs5.10 Billion ≈ $55.11 Million |
Rs2.42 Billion ≈ $26.14 Million |
0.474x | +164.43% |
| 2007-03-31 | Rs4.10 Billion ≈ $44.37 Million |
Rs735.97 Million ≈ $7.96 Million |
0.179x | +81.59% |
| 2006-03-31 | Rs3.48 Billion ≈ $37.62 Million |
Rs343.63 Million ≈ $3.72 Million |
0.099x | +23.72% |
| 2005-03-31 | Rs3.16 Billion ≈ $34.12 Million |
Rs251.96 Million ≈ $2.72 Million |
0.080x | -- |
About Torrent Pharmaceuticals Limited
Torrent Pharmaceuticals Limited engages in the research, development, manufacturing, marketing, and distribution of branded and generic pharmaceutical formulations in India, the United States, Brazil, Germany, and internationally. The company offers products in various therapeutic areas, including anti-diabetic, anti-microbial, cardiovascular, urology, gynecology, oncology, gastro-intestinal, nep… Read more